WntResearch is active in biotechnology. Today the main focus is on the development of drug candidates for various metastatic forms of cancer. The research is focused on studying the bodily-specific protein WNT-5a, which has been found to play a crucial role in the proliferation of tumour cells. The products are licensed to various stakeholders in the industry. The head office is in Malmö.

Quotes for WntResearch AB

Right Now

+/-
-0.009
%
-2,73%
Latest
0.321
High
0.338
Low
0.32
Volume
358 181
Turnover (SEK)
117 460
Market Value (MSEK)
76,6
Time (Latest trade)

Board

CEO

  • Pernilla Sandwall

Chairperson of the Board

  • Christer Nordstedt

Board

  • Bengt Gustavsson
  • Gudrun Anstrén
  • Janna Sand-Dejmek
  • Peter Ström
  • Tommy Andersson

Videos

Upcoming reports

  • 2023-02-09 Bokslutskommuniké 2022

  • 2023-05-04 Delårsrapport 2023-Q1

  • 2023-06-01 Årsstämma 2022

  • 2023-08-17 Delårsrapport 2023-Q2

  • 2023-11-16 Delårsrapport 2023-Q3